Sensitization of androgen refractory prostate cancer cells to anti-androgens through re-expression of epigenetically repressed androgen receptor–synergistic action of quercetin … V Sharma, L Kumar, SK Mohanty, JP Maikhuri, S Rajender, G Gupta Molecular and cellular endocrinology 431, 12-23, 2016 | 60 | 2016 |
Apigenin manipulates the ubiquitin–proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells V Singh, V Sharma, V Verma, D Pandey, SK Yadav, JP Maikhuri, G Gupta European journal of nutrition 54, 1255-1267, 2015 | 49 | 2015 |
Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re‐expressing the epigenetically repressed tumor … V Sharma, V Verma, N Lal, SK Yadav, S Sarkar, D Mandalapu, K Porwal, ... Molecular Carcinogenesis 55 (11), 1843-1857, 2016 | 46 | 2016 |
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines D Mandalapu, KS Saini, S Gupta, V Sharma, MY Malik, S Chaturvedi, ... Bioorganic & Medicinal Chemistry Letters 26 (17), 4223-4232, 2016 | 41 | 2016 |
Anticancer effect of nor-wogonin (5, 7, 8-trihydroxyflavone) on human triple-negative breast cancer cells via downregulation of TAK1, NF-κB, and STAT3 AAA El-Hafeez, HO Khalifa, EAM Mahdy, V Sharma, T Hosoi, P Ghosh, ... Pharmacological Reports 71, 289-298, 2019 | 33 | 2019 |
Oleanolic–bioenhancer coloaded chitosan modified nanocarriers attenuate breast cancer cells by multimode mechanism and preserve female fertility M Sharma, S Sharma, V Sharma, K Sharma, SK Yadav, P Dwivedi, ... International Journal of Biological Macromolecules 104, 1345-1358, 2017 | 26 | 2017 |
Therapeutic potential of p53 reactivation in prostate cancer: Strategies and opportunities S Kumari, V Sharma, R Tiwari, JP Maurya, BB Subudhi, D Senapati European Journal of Pharmacology 919, 174807, 2022 | 25 | 2022 |
Combining a synthetic spermicide with a natural trichomonacide for safe, prophylactic contraception A Jain, L Kumar, B Kushwaha, M Sharma, A Pandey, V Verma, V Sharma, ... Human Reproduction 29 (2), 242-252, 2014 | 20 | 2014 |
Energy utilization for survival and fertilization—parsimonious quiescent sperm turn extravagant on motility activation in rat L Kumar, SK Yadav, B Kushwaha, A Pandey, V Sharma, V Verma, ... Biology of reproduction 94 (4), 96, 1-9, 2016 | 18 | 2016 |
Novel alkylphospholipid-DTC hybrids as promising agents against endocrine related cancers acting via modulation of Akt-pathway S Jangir, V Bala, N Lal, L Kumar, A Sarswat, A Kumar, KS Saini, ... European Journal of Medicinal Chemistry 85, 638-647, 2014 | 16 | 2014 |
Labda‐8(17),12,14‐trien‐19‐oic Acid Contained in Fruits of Cupressus sempervirens Suppresses Benign Prostatic Hyperplasia in Rat and In Vitro Human Models … V Verma, V Sharma, V Singh, R Kumar, MF Khan, AK Singh, R Sharma, ... Phytotherapy Research 28 (8), 1196-1203, 2014 | 16 | 2014 |
Design of folic acid conjugated chitosan nano-cur–bioenhancers to attenuate the hormone-refractory metastatic prostate carcinoma by augmenting oral bioavailability M Sharma, S Sharma, V Sharma, S Agarwal, P Dwivedi, SK Paliwal, ... RSC advances 6 (30), 25137-25148, 2016 | 14 | 2016 |
Design, synthesis and biological profiling of aryl piperazine based scaffolds for the management of androgen sensitive prostatic disorders S Gupta, D Pandey, D Mandalapu, V Bala, V Sharma, M Shukla, ... Medchemcomm 7 (11), 2111-2121, 2016 | 11 | 2016 |
Designed chemical intervention with thiols for prophylactic contraception M Sharma, L Kumar, A Jain, V Verma, V Sharma, B Kushwaha, N Lal, ... PloS one 8 (6), e67365, 2013 | 9 | 2013 |
Novel aryl piperazines for alleviation of ‘andropause’associated prostatic disorders and depression S Gupta, D Pandey, D Mandalapu, V Sharma, M Shukla, S Singh, N Singh, ... European Journal of Medicinal Chemistry 132, 204-218, 2017 | 8 | 2017 |
Designed modulation of sex steroid signaling inhibits telomerase activity and proliferation of human prostate cancer cells V Verma, V Sharma, V Singh, S Sharma, AK Bishnoi, V Chandra, ... Toxicology and applied pharmacology 280 (2), 323-334, 2014 | 7 | 2014 |
Functional implications and therapeutic targeting of androgen response elements in prostate cancer D Senapati, V Sharma, SK Rath, U Rai, N Panigrahi Biochimie, 2023 | 6 | 2023 |
Re-Expression of ERα and AR in Receptor Negative Endocrine Cancers via GSK3 Inhibition V Sharma, J Joshi, IJ Yeh, YQ Doughman, D Blankenberg, D Wald, ... Frontiers in Oncology 12, 824594, 2022 | 4 | 2022 |
A precisely substituted benzopyran targets androgen refractory prostate cancer cells through selective modulation of estrogen receptors R Kumar, V Verma, V Sharma, A Jain, V Singh, A Sarswat, JP Maikhuri, ... Toxicology and Applied Pharmacology 283 (3), 187-197, 2015 | 4 | 2015 |
Non-epigenetic induction of HEXIM1 by DNMT1 inhibitors and functional relevance V Sharma, MM Montano Scientific Reports 10 (1), 21015, 2020 | 2 | 2020 |